APA (7th ed.) Citation

Ning, X., Nguyễn, T. T. T., Morinaga, T., Tada, Y., Shimada, H., Hiroshima, K., . . . Tagawa, M. (2026). Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype. PLoS ONE, 21(2), 1. https://doi.org/10.1371/journal.pone.0343551

Chicago Style (17th ed.) Citation

Ning, Xuerao, Thảo Thi Thanh Nguyễn, Takao Morinaga, Yuji Tada, Hideaki Shimada, Kenzo Hiroshima, Naoto Yamaguchi, and Masatoshi Tagawa. "Strategic Selection of MDM2 Inhibitors Enhances the Efficacy of FAK Inhibition in Mesothelioma Based on TP53 Genotype." PLoS ONE 21, no. 2 (2026): 1. https://doi.org/10.1371/journal.pone.0343551.

MLA (9th ed.) Citation

Ning, Xuerao, et al. "Strategic Selection of MDM2 Inhibitors Enhances the Efficacy of FAK Inhibition in Mesothelioma Based on TP53 Genotype." PLoS ONE, vol. 21, no. 2, 2026, p. 1, https://doi.org/10.1371/journal.pone.0343551.